Jane S. Vergnes, Ph.D., DABT®
Director of Toxicology

T: 202-266-5030
F: 202-557-3836
Download vCard

BA, Ohio Wesleyan University, Bacteriology, 1974

Ph.D., University of Pittsburgh, Human Genetics, 1982



Director of Toxicology for B&C® Consortia Management, L.L.C. (BCCM), Dr. Vergnes provides BCCM's clients with toxicology expertise for the broad range of research, testing, regulatory, and advocacy goals our consortium members seek. An experienced leader in global product stewardship, she offers clients an agile, multi-disciplinary talent for problem-solving honed in her 25 years directing product stewardship and toxicology departments for Ashland, Inc., International Specialty Products (ISP), Texaco, and Union Carbide (now Dow).  Dr. Vergnes is also an experienced research scientist and scientific study director with a Ph.D. in Human Genetics and a specialization in the genetic/epigenetic modes of action of toxicants, and she deploys the full depth of her scientific, business, and policy knowledge to resolve clients' challenges.

Dr. Vergnes came to BCCM from Ashland, Inc., a Fortune 500-listed global specialty chemical company.  As Senior Manager, Toxicology and Regulatory Programs, at Ashland, Dr. Vergnes was responsible for practices and procedures followed by all toxicologists in the company globally, including oversight of chemical regulatory programs and chemical registrations, Toxic Substances Control Act (TSCA) chemical data reporting, and comparable programs in the many countries in which Ashland operates, drug precursor regulations, chemical weapons convention compliance, California Proposition 65 compliance, and hazard communication.  Prior to Ashland, Dr. Vergnes served as Senior Director of Global Product Stewardship for ISP, where she managed toxicology, hazard communication, and product regulatory affairs programs for all industrial and specialty chemical ingredient product lines, including personal care ingredients, household and industrial ingredients, biocides, performance chemicals, acetylenics, food and beverage, pharmaceutical excipients, tablet coating systems, encapsulation technologies, and elastomers.


2200 Pennsylvania Avenue, NW, Suite 100W
Washington, D.C. 20037
202-833-6580 | bc-cm.com
Contact • Twitter
Privacy Policy | Terms of Use | Cookie Policy 
©2019 B&C Consortia Management, L.L.C.
All Rights Reserved.